Actually there are about 2,500 people world wide with CMT. 150,000 in the U.S. alone. Treatment/cure has a long road ahead. Many, many types and subtypes of it. It's considered an orphan disease so not much interest for companies to make a drug where so few, so to speak, would use it. And it would take a long, long time to do it.